CRACD expression greater than the mean achieved significance in 6 of the 29 tumor types, including 3 where IFT57 was most significantly associated with overall survival: lower-grade glioma, lung adenocarcinoma, and papillary thyroid carcinoma. This evidence concerns the gene IFT57 and central nervous system cancer.